Eden Research plc
LSE : EDE

February 23, 2011 02:00 ET

Granting of nematodes patent

                                                                                                      
                                                                             GB0001646941/GBP/PLUS-exn
                                                                                      23 February 2011
                                                   
                                           EDEN RESEARCH PLC
                                       ("Eden" or the "Company")

                                     Granting of nematodes patent

Eden  Research  plc, a leading UK agrochemical development company, is pleased to announce  the  first
granting  of its 'nematodes' patent in Australia. The patent, which is for the use of Eden's  platform
encapsulation  technology with terpenes as a nematicide, is also in an advanced state of  registration
in a number of other countries. The patented encapsulation system itself has already been granted in a
number of territories.

Nematodes  are  microscopic, soil-dwelling worms measuring approximately 0.1-5 mm in length.  Nematode
populations  can  cause  considerable  damage  to a wide  range  of  high-value  vegetable  crops  and
horticultural species.

Eden  has already licensed its nematicide product in South America to Stockton Agrimor AG and  granted
an  option  for  the product to Certis Europe BV to enter into an exclusive licence for Europe,  Asia,
Africa, the Middle East and Oceania.

Clive  Newitt, Managing Director of Eden Research plc said, "The nematode market has been as  high  as
$1.1bn  worldwide  but  due  to  regulatory  withdrawal of many  previous  products,  such  as  Temik®
(aldicarb),  there is a vacuum waiting to be filled by naturally derived, effective, cost  competitive
products such as Eden's.

The  granting  of this patent is important not only for the nematode licences that we have  signed  to
date, but, also for reinforcing the value of the company's intellectual property."

The Directors of Eden are responsible for the contents of this announcement.

Enquiries:

Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl

Notes:

Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology  for  agricultural  and  non-agricultural  uses  through  appropriate  regional  or  global
partnerships.

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk
agrochemicals.

For more information, please visit www.edenresearch.com

Contact Information

  • Eden Research plc